UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Investigating the stomatal, cuticular and soil ammonia fluxes over a growing tritical crop under high acidic loads

Biogeosciences, 2012-04, Vol.9 (4), p.1537-1552

2012

Volltextzugriff (PDF)

Volatile organic compound fluxes over a winter wheat field by PTR-Qi-TOF-MS and eddy covariance

Atmospheric chemistry and physics, 2022-03, Vol.22 (4), p.2817-2842

2022

Volltextzugriff (PDF)

Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function

The Journal of pharmacology and experimental therapeutics, 2001-11, Vol.299 (2), p.449

2001

Volltextzugriff (PDF)

Nitrogen oxides and ozone fluxes from an oilseed-rape management cycle: the influence of cattle slurry application

Biogeosciences, 2017-05, Vol.14 (8), p.2225-2244

2017

Volltextzugriff (PDF)

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

Proceedings of the National Academy of Sciences - PNAS, 1993-01, Vol.90 (1), p.65-69

1993

Volltextzugriff (PDF)

Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors

Neuropharmacology, 1994-02, Vol.33 (2), p.167-179

1994

Volltextzugriff (PDF)

Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats

Psychopharmacologia, 1994-10, Vol.116 (2), p.237-241

1994

Volltextzugriff (PDF)

Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists

Naunyn-Schmiedeberg's archives of pharmacology, 1994-01, Vol.349 (1), p.57-60

1994

Volltextzugriff (PDF)

Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A

Neuropharmacology, 1993-06, Vol.32 (6), p.605-615

1993

Volltextzugriff (PDF)

Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat

Fundamental & clinical pharmacology, 1998-01, Vol.12 (1), p.88-94

1998

Volltextzugriff (PDF)

Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats

Psychopharmacologia, 1989-01, Vol.98 (2), p.286-288

1989

Volltextzugriff (PDF)

Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist

Naunyn-Schmiedeberg's archives of pharmacology, 1993-07, Vol.348 (1), p.102-107

1993

Volltextzugriff (PDF)

The CCKA Receptor Antagonist SR 27897 Differentially Influences the Activity of A9 and A10 Dopaminergic Neurons in the Rat

Annals of the New York Academy of Sciences, 1994-03, Vol.713 (1), p.364-367

1994

Volltextzugriff (PDF)

A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum

The Journal of biological chemistry, 1988-08, Vol.263 (22), p.10641-10645

1988

Volltextzugriff (PDF)

Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs

Synapse (New York, N.Y.), 1999-07, Vol.33 (1), p.71-79

1999

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist

Canadian journal of physiology and pharmacology, 2002-05, Vol.80 (5), p.482

2002

Volltextzugriff (PDF)

Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons

Neuroreport, 2000-05, Vol.11 (7), p.1437-1441

2000

Volltextzugriff (PDF)

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.752

1999

Volltextzugriff (PDF)

The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat

Neuroreport, 1995-07, Vol.6 (10), p.1421-1425

1995

Volltextzugriff (PDF)

Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade

Synapse (New York, N.Y.), 1997-08, Vol.26 (4), p.370-380

1997

Volltextzugriff (PDF)

Turning behavior induced in mice by a neurokinin A receptor agonist: Stereoselective blockade by SR 48968, a non-peptide receptor antagonist

Neuroscience letters, 1993-01, Vol.149 (1), p.40-42

1993

Volltextzugriff (PDF)

The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception

European journal of pharmacology, 1993-06, Vol.237 (1), p.143-146

1993

Volltextzugriff (PDF)

The CB sub(1) cannabinoid receptor antagonist SR 141716A affects A sub(9) dopamine neuronal activity in the rat

Neuroreport, 1995-01, Vol.6 (10), p.1421-1425

1995

Volltextzugriff (PDF)

Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: Pharmacological analysis of a simple screening model

Life sciences (1973), 1986-12, Vol.39 (23), p.2199-2208

1986

Volltextzugriff (PDF)

The CCK A Receptor Antagonist SR 27897 Differentially Influences the Activity of A 9 and A 10 Dopaminergic Neurons in the Rat

Annals of the New York Academy of Sciences, 1994-03, Vol.713 (1), p.364-367

1994

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Französisch
(53)
Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Investigating the stomatal, cuticular and soil ammonia fluxes over a growing tritical crop under high acidic loads

Volatile organic compound fluxes over a winter wheat field by PTR-Qi-TOF-MS and eddy covariance

Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function

Nitrogen oxides and ozone fluxes from an oilseed-rape management cycle: the influence of cattle slurry application

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors

Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats

Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists

Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A

Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat

Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats

Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist

The CCKA Receptor Antagonist SR 27897 Differentially Influences the Activity of A9 and A10 Dopaminergic Neurons in the Rat

A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum

Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist

Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization

The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat

Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade

Turning behavior induced in mice by a neurokinin A receptor agonist: Stereoselective blockade by SR 48968, a non-peptide receptor antagonist

The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception

The CB sub(1) cannabinoid receptor antagonist SR 141716A affects A sub(9) dopamine neuronal activity in the rat

Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: Pharmacological analysis of a simple screening model

The CCK A Receptor Antagonist SR 27897 Differentially Influences the Activity of A 9 and A 10 Dopaminergic Neurons in the Rat

Suchergebnisse filtern